Brian Finrow

Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington.

Trillium Corp. invests in real estate and forestry. The company also provides land for preservation and scientific research, community parks, bald eagle communal night roosts, heron habitats, and Peregrine falcon roosting sites. Its other assets include business parks and office and medical buildings. The company was founded by David R. Syre and Kay E. Syre in 1974 and is headquartered in Bellingham, WA.

Trillium Asset Management LLC is a SEC-registered investment advisor headquartered in Boston, Massachusetts. The firm was founded by Joan Bavaria in 1982 as Franklin Research & Development Co. Trillium Asset Management manages equity, fixed income, and balanced separate accounts for individuals, foundations, endowments, religious institutions and other non-profit and for-profit institutional clients.

Founded in 1979, Matthew G. Norton Co. is a real estate investment, development and management firm located in Seattle, Washington.

Nervana is dedicated to the innovation of leading knowledge discovery technologies that enable knowledge based workers to more efficiently find, correlate and retrieve the information from vast repositories both inside and outside their enterprise. The industry leading Nervana Discovery Solution is an intelligent knowledge discovery technology that understands and efficiently translates the true semantic meaning of the inquiry, enabling direct access to meaningful data. The explosive growth of digital information, while improving the access to data, is impeding knowledge worker's productivity. Information repositories are virtually doubling every year and most of that information is unstructured usually in the form of text. Traditional search engines have been unable to keep up with the pace of information growth primarily because they lack the intelligence to 'understand,' semantically process, mine, infer, connect, and contextually interpret information in order to transform it to and expose it as knowledge.

Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.

Clario Medical Imaging, Inc. develops diagnostic imaging equipment. It also offers tool workflow management software. The firm solutions include private practice and health subsystems. The company was founded by Chris Wood in 2005 and is headquartered in Seattle, WA.

RoosterBio, Inc. provides standardized stem cell platforms that enable clinical and commercial translation. Its products include bioprocess media, plug and play systems, clinical control, and roosterbio swag products. The company was founded Jon A. Rowley in 2013 and is headquartered in Frederick, MD.

University of Washington functions as a College/University. The company is headquartered in Seattle, WA.

Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis.

Northwest Venture Associates LLC (Northwest Venture) is a venture capital firm founded by Tom Simpson in 1995. The firm is headquartered in Washington, United States.

Part of General Word Ventures LLC, Educational Holdings LLC is a company that offers educational products for kids. The company is based in West Beverly Hills, CA. Educational Holdings was acquired by WuWul LLC on September 02, 2014.

America's Foundation for Chess provides chess training for school children. The non-profit company is based in Kirkland, WA. The company was founded by Erik J. Anderson.

Golf Entertainment International, Inc. operates golf driving ranges.

WestRiver Management LLC (WestRiver Management) is a venture capital firm founded in 2002 by Erik J Anderson. The firm is headquartered in Seattle, Washington.

ONEHOPE, Inc. engages in the production and selling of wine and coffee. Its brands include viaONEHOPE, Estate8, and Foundation. The company was founded by Jacob Kloberdanz, Thomas Leahy, Blake Petty, Brandon Hall, Tiffany Wojtkiewicz, Sarah Gora McPeake, Logan W. Allin and Kristen Lyn Shroyer in 2007 and is headquartered in Santa Ana, CA.

Bioeconomy Capital LLC (Bioeconomy Capital) is a venture capital firm founded in 2014 by Rob Carlson and Rik Wehbring. The firm is headquartered in Seattle, Washington.

TOCA Football, Inc. operates as a a soccer-focused, technology-enabled experience company. It develops a football training technology based machine. Its application delivers small soccer balls at specified speeds and locations. The company was founded by Edward Lewis in 2014 and is headquartered in Costa Mesa, CA.

Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California.

Procom Corp. engages in communication solutions services. It offers convert systems, portable radios, mobile radios / base stations, repeater systems, radio / smartphone interop, accessories for 2-way radios, batteries /chargers, transportable repeaters, instant alert systems, pronet dispatch solutions, radio dispatch solutions, radio dispatch consoles, in building coverage, and grab-n-go kits. The firm also provide services such as system design, installation and maintenance, radio repair, and federal communications commission licensing. The company is headquartered in Jessup, MD.

ImmunOs Therapeutics AG is a company based in Schlieren, Switzerland that pioneers HLA-based therapeutics to create transformational medicines for cancer and inflammation. The Swiss company has identified specific HLA molecules that activate the immune system and is utilizing these molecules as the backbone of novel therapies capable of stimulating both the innate and adaptive immune systems of cancer patients to eliminate tumor cells. ImmunOs' lead program is a multi-functional fusion protein that blocks specific LILRB and KIR receptors and activates anti-tumor responses. The company is also using HLA molecules to develop novel therapies to treat inflammatory diseases. ImmunOs is supported by leading international investors, including Samsara BioCapital, Lightspeed Venture Partners, Gimv, Pfizer Ventures, Biomed Partners, Schroder Adveq, Mission BioCapital, GL Capital, Peak6, Fiscus, and Redalpine. The company was founded by Osiris Marroquin Belaunzaran and Christoph Renner, and the CEO is Sean R. Smith.

Enlaza Therapeutics, Inc. is a company that develops novel classes of protein therapeutics using their proprietary war-lock™ platform. The company is based in La Jolla, CA. The company's platform utilizes synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza Therapeutics is pioneering the field of covalent biologics and aims to deliver more efficacious and safer treatments for patients. The CEO of the company is Sergio G. Duron.